Table: Zeria Pharm -2021/22 group results

Zeria Pharmaceutical

11/05/2022 08:00

May 11 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           59.53           52.76          66.00        33.00    
               (+12.8 pct)                    (+10.9 pct)  (+15.4 pct) 
  Operating        6.37            3.48           7.00         3.50    
               (+83.2 pct)                    (+10.0 pct)  (+31.0 pct) 
  Recurring        5.94            3.21           7.00         3.50    
               (+85.0 pct)                    (+17.9 pct)  (+12.3 pct) 
  Net
  Net              3.96            3.14           5.60         2.80    
               (+26.0 pct)                    (+41.4 pct)  (+32.3 pct) 
  EPS           87.76 yen       68.22 yen     126.10 yen    63.05 yen  
  Ann Div       35.00 yen       34.00 yen      36.00 yen               
  -Q2 Div       17.00 yen       17.00 yen      18.00 yen               
  -Q4 Div       18.00 yen       17.00 yen      18.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T